Tata Chemicals (TATACHEM)

Cyclical

FairStock Score: 20/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹670.65
Market Cap₹17,085.23 Cr
P/E Ratio67.18
ROCE3.96%
ROE0.83%
Dividend Yield1.64%
Profit Growth11.73%
Debt/Equity0.36
Sales Growth8.24%
Free Cash Flow₹94 Cr
Promoter Holding37.98%
52-Week Range₹570.1 — ₹915.15
SectorChemicals & Petrochemicals
Book Value₹832.4

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

As a Graham-style value investor, I see Tata Chemicals as a commodity chemical cyclical, not a wonderful business. At ₹670.65 and a market cap of ₹17,085 Cr, the market asks a lot. The P/B of 0.81 and book value of ₹832.40 make it look like an asset play, but the Graham Number is ₹366.94, giving a margin of safety of -95.51%. My DCF intrinsic value is only ₹68.73, and EV/EBITDA is 220.66. Those numbers tell me earnings power is weak and the price is not conservative. ROE is 0.83% and ROCE is 3.96%, far below what I want. The latest quarter had sales of ₹3,550 Cr but a net loss of ₹69 Cr. Debt/Equity of 0.36 is manageable, and free cash flow of ₹94 Cr is positive, so the balance sheet is not the main problem. Sales growth of 8.24%, profit growth of 11.73%, and a five-year revenue CAGR of 7.53% are modest. Dividend yield is only 1.64%, promoter holding is 37.98%. The Piotroski F-Score is 5/9, Altman Z-Score 1.40, PEG 3.81, and FairStock Score 20/100 RISKY. Commodity chemicals often lack durable pricing power, and the returns here do not show a moat. I would wait for cycle recovery, better ROCE, and a price closer to intrinsic value. The stock may be a cyclical asset play, but not a Buffett-quality compounder at this quote.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer